Allocations
G-Therapeutics has secured up to EUR26 million in a Series A financing round from an investment syndicate consisting of Gimv, Wellington Partners, LSP and Inkef Capital alongside the company’s founders/management.
This investment will fund the company’s clinical trials up to CE mark (EU) and IDE (US) approval.
G-Therapeutics (http://gtherapeutics.com/#About) develops an implantable neuro stimulator for patients with incomplete spinal cord injury. The company’s device supports motor function recovery for better and faster rehabilitation by stimulating the spinal cord. The company was founded in 2014 as a spin-off of the Center for Neuro-Prosthetics of the renowned École Polytechnique Fédérale de Lausanne
BFF Nonwovens has secured a multi-million pound funding package from BGF (Business Growth Fund) and Lloyds Bank to pursue its growth ambitions in the UK and overseas.
Based in Bridgwater, Somerset, the company specialises in the production of high quality, bespoke technical fabrics for niche markets. Its products have a range of different end uses including filtration, packaging, acoustics and advanced wound care. BFF has invested in its manufacturing facilities to provide capacity across all of its product lines in both its Bridgwater and Bolton sites.
Under the leadership of David Lamb, Andrew Brownlow and Chris Burhop, the business has
Chemical technology company Avantium has closed a financing round of EUR20 million led by PMV, an independent investment company for Flanders, FPIM, a Belgian Federal Holding and Investment Company, and Avantium’s existing shareholders.
The funds will be used to commercialize the YXY technology for producing 100 per cent biobased packaging material PEF (polyethylenefuranoate), a next generation plastic with superior performance.
Avantium’s roll-out plan includes the construction of a ‘reference plant’, the world’s first commercial plant to produce FDCA (furandicarboxylic acid). This reference plant with a capacity of up to 50,000 metric tons per year is intended to be located in
The Chartered Alternative Investment Analyst (CAIA) Association, a global leader in alternative investment education, has embarked on its first international branding campaign.
Titled “Mind the Gap,” CAIA’s new campaign incorporates creative advertising in the London Underground system, social media outreach to CAIA Members and prospective Members, and educational events designed to help professionals in various alternative investing disciplines better understand the changing nature of the space and the ways in which education can help them build and maintain the relevant skills, while advancing their careers.
“We chose to launch the Mind the Gap campaign in London since it is
Edmond de Rothschild Asset Management has launched the Edmond de Rothschild Fund UK Synergy, available through the Edmond de Rothschild Fund UCITS umbrella domiciled in Luxembourg.
The equity fund seeks to capture upside on UK stocks that are possible bid targets and/or undergoing restructuring.
Edmond de Rothschild Fund UK Synergy invests across the whole spectrum of UK equities (circa 600 stocks). It aims to generate consistent outperformance over a complete business cycle through two complementary drivers. The fund draws upon the selection of stocks potentially targeted in takeover deals, as well as companies that may benefit from restructuring opportunities.
Ambienta has led the acquisition of Calucem Group (Calucem) from ARGUS Capital Partners II.
Calucem ranks No2 in the world as a Calcium Aluminate Cements (CAC) developer, manufacturer and distributor and is one of only a few competitors with global reach in the sector. With annual revenues approaching EUR50 million, Calucem sells in more than 60 countries, with the US and Germany being the largest. As a global player, Calucem operates through an R&D and commercial centre in Mannheim (D), operations in Pula (HR), sales and marketing offices in the US and Singapore, a bauxite quarry in Izmir (TR) with
z9 Capital (z9) has launched a USD25 million venture capital fund at eMerge Americas. z9 invests USD250,000-USD4 million in early-stage, founder-led companies that have demonstrated product-market fit and are seeking growth capital.
z9’s investment thesis is rooted in active management and is the first of its kind, in South Florida, to provide startups with both the liquidity and the operational resources needed to not only succeed – but thrive.
Founded in 2014, the boutique venture firm has made waves in South Florida with their unique active management investment approach. Having invested heavily in an operational infrastructure that includes sales, marketing,
North West-based specialist medical and healthcare broker, Nugent Santé is to embark on expansion plans following the acquisition of 50 per cent of its business by the MAC Group for an undisclosed sum.
Nugent Santé, which was formed last year by its managing director, Paul Nugent, officially launched in January 2016 but already manages in excess of GBP5 million of annual insurance premium for private and corporate clients.
The company, which employs 10 people from its Lancashire headquarters, is aiming to distance itself from other brokers by offering a rounded proposition that focuses on keeping clients healthy and then
The Capital Partnership, a private investment office and independent asset manager, is to acquire Northgate Capital, the California-based venture capital and private equity investment firm, from Religare and members of the firm’s management team.
Religare, the India-based diversified financial services group, acquired a majority interest in Northgate in 2010. Completion of the transaction is subject to the satisfaction of certain conditions precedent, including certain regulatory approvals. Terms of the transaction were not disclosed.
Founded in 2000, Northgate is a leading venture capital and private equity firm with USD4.8 billion in assets under management (AUM) as of 1 April 2016 on
Geli, a supplier of software and networking solutions to the energy storage industry, has completed a USD7 million Series A funding round led by a clean energy investment office and Shell Technology Ventures.
Shell Technology Ventures (STV), the venture division of globally integrated energy company Royal Dutch Shell (RDS.A), brings Geli into a growing portfolio of breakthrough cleantech companies.
Geli’s end-to-end software platform speeds time to market for OEMs and hardware integrators, accelerates the sales cycle for project developers, and provides assurance of system performance to host customers and financiers. The Series A funding will extend Geli’s engineering capacity
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
